Ibercaja Sanidad FI focuses on investing primarily in international healthcare companies, dedicating at least three-quarters of its portfolio to equities like pharmaceutical and biotechnology firms, medical equipment manufacturers, healthcare service providers, and technology suppliers based mainly in the United States, Europe, and Japan. The fund includes a mix of large-cap as well as selected mid and small-cap companies involved in research, development, and production of medical technologies and drugs. Additionally, up to 25% of the portfolio is invested in high-quality fixed income securities from reputable public and private issuers within developed markets.